OTCMKTS:BMXMF

bioMérieux News Headlines

$134.50
-2.55 (-1.86 %)
(As of 04/16/2021 12:00 AM ET)
Add
Compare
Today's Range
$134.50
Now: $134.50
$134.50
50-Day Range
$123.00
MA: $128.96
$137.28
52-Week Range
$111.50
Now: $134.50
$170.55
Volume200 shs
Average Volume190 shs
Market Capitalization$15.92 billion
P/E Ratio52.13
Dividend YieldN/A
Beta0.15

Headlines

bioMérieux (OTCMKTS BMXMF) News Headlines Today

SourceHeadline
bioMérieux S.A. (OTCMKTS:BMXMF) Given Average Rating of "Hold" by AnalystsbioMérieux S.A. (OTCMKTS:BMXMF) Given Average Rating of "Hold" by Analysts
americanbankingnews.com - April 14 at 7:22 AM
bioMérieux (OTCMKTS:BMXMF) Shares Up 4%bioMérieux (OTCMKTS:BMXMF) Shares Up 4%
americanbankingnews.com - April 14 at 12:19 AM
bioMérieux - 2020 Financial ResultsbioMérieux - 2020 Financial Results
finanznachrichten.de - March 23 at 11:54 PM
bioMérieux - First-Half 2020 ResultsbioMérieux - First-Half 2020 Results
finanznachrichten.de - September 29 at 9:26 AM
French labs show how global supply bottlenecks thwart effort to ramp up testingFrench labs show how global supply bottlenecks thwart effort to ramp up testing
finance.yahoo.com - September 27 at 7:10 PM
What Makes BIOMERIEUX (BMXMF) a New Buy StockWhat Makes BIOMERIEUX (BMXMF) a New Buy Stock
finance.yahoo.com - September 10 at 1:52 PM
COVID-19 Diagnostics Market Clinical Reviews by Expert and Healthcare Analysis 2020COVID-19 Diagnostics Market Clinical Reviews by Expert and Healthcare Analysis 2020
marketwatch.com - September 5 at 12:27 AM
bioMérieux SA (BMXMF) CEO Alexandre Mérieux on Q2 2020 Results - Earnings Call TranscriptbioMérieux SA (BMXMF) CEO Alexandre Mérieux on Q2 2020 Results - Earnings Call Transcript
seekingalpha.com - September 3 at 6:11 PM
bioMérieux S.A. 2020 Q2 - Results - Earnings Call PresentationbioMérieux S.A. 2020 Q2 - Results - Earnings Call Presentation
seekingalpha.com - September 2 at 10:09 PM
What Makes BIOMERIEUX (BMXMF) a New Strong Buy StockWhat Makes BIOMERIEUX (BMXMF) a New Strong Buy Stock
finance.yahoo.com - July 27 at 3:18 PM
BIOFIRE® Respiratory Panel 2.1 plus with SARS-CoV-2 is CE markedBIOFIRE® Respiratory Panel 2.1 plus with SARS-CoV-2 is CE marked
finance.yahoo.com - July 15 at 8:35 AM
bioMérieux: Description of the New Share Buyback Program Pursuant to Article 241-1 to Article 241-6 of the AMF General RegulationsbioMérieux: Description of the New Share Buyback Program Pursuant to Article 241-1 to Article 241-6 of the AMF General Regulations
finance.yahoo.com - June 30 at 1:37 PM
bioMérieux Issues a €200 Million Euro PP BondbioMérieux Issues a €200 Million Euro PP Bond
finance.yahoo.com - June 29 at 6:04 PM
Drugs standards group nixes plan to kick pharmas crab blood habitDrugs standards group nixes plan to kick pharma's crab blood habit
finance.yahoo.com - May 30 at 1:26 PM
All You Need to Know About BIOMERIEUX (BMXMF) Rating Upgrade to BuyAll You Need to Know About BIOMERIEUX (BMXMF) Rating Upgrade to Buy
finance.yahoo.com - May 27 at 2:27 PM
bioMérieux: Notice of Information Related to Preparatory Documents for the Ordinary and Extraordinary Shareholders’ Meeting of June 30, 2020bioMérieux: Notice of Information Related to Preparatory Documents for the Ordinary and Extraordinary Shareholders’ Meeting of June 30, 2020
finance.yahoo.com - May 23 at 2:34 PM
CE Marking of bioMérieux Serology Tests for SARS-CoV-2 on VIDAS®CE Marking of bioMérieux Serology Tests for SARS-CoV-2 on VIDAS®
finance.yahoo.com - May 21 at 2:23 PM
Information Concerning 2019 Dividend and the bioMérieux General Shareholders’ MeetingInformation Concerning 2019 Dividend and the bioMérieux General Shareholders’ Meeting
finance.yahoo.com - May 19 at 3:21 PM
bioMérieux Serology Tests for SARS-CoV-2 on VIDAS® Undergo Validation Preceding Imminent LaunchbioMérieux Serology Tests for SARS-CoV-2 on VIDAS® Undergo Validation Preceding Imminent Launch
finance.yahoo.com - May 6 at 1:56 AM
bioMérieux S.A. (EPA:BIM) Earns A Nice Return On Capital EmployedbioMérieux S.A. (EPA:BIM) Earns A Nice Return On Capital Employed
finance.yahoo.com - May 4 at 6:51 AM
BioMerieux COVID testing product gets U.S. emergency use authorizationBioMerieux COVID testing product gets U.S. emergency use authorization
finance.yahoo.com - May 4 at 1:51 AM
bioMérieux – First-Quarter 2020 Business ReviewbioMérieux – First-Quarter 2020 Business Review
finance.yahoo.com - April 16 at 1:29 AM
bioMérieux’s Annual General Meeting PostponedbioMérieux’s Annual General Meeting Postponed
finance.yahoo.com - April 9 at 7:03 PM
What Is bioMérieux's (EPA:BIM) P/E Ratio After Its Share Price Rocketed?What Is bioMérieux's (EPA:BIM) P/E Ratio After Its Share Price Rocketed?
finance.yahoo.com - April 2 at 2:50 AM
Is bioMérieux S.A.'s (EPA:BIM) ROE Of 12% Impressive?Is bioMérieux S.A.'s (EPA:BIM) ROE Of 12% Impressive?
finance.yahoo.com - March 29 at 6:54 AM
Health Care Stocks Lead European Quarter in Pandemic’s GripHealth Care Stocks Lead European Quarter in Pandemic’s Grip
finance.yahoo.com - March 29 at 1:53 AM
USA: A Brutal Post-Coronavirus Economic ResetUSA: A Brutal Post-Coronavirus Economic Reset
seekingalpha.com - March 25 at 5:12 PM
European shares trudge higher as stimulus wave stems selloffEuropean shares trudge higher as stimulus wave stems selloff
finance.yahoo.com - March 24 at 5:37 AM
European stocks and U.S. futures jump amid tentative signs of Italy curbing virus spreadEuropean stocks and U.S. futures jump amid tentative signs of Italy curbing virus spread
finance.yahoo.com - March 24 at 5:37 AM
bioMérieux: Regulated Information – Disclosure of Trading in Own SharesbioMérieux: Regulated Information – Disclosure of Trading in Own Shares
finance.yahoo.com - March 19 at 7:29 PM
First of 3 Diagnostic Tests for SARS-CoV-2 Coronavirus Available from bioMérieuxFirst of 3 Diagnostic Tests for SARS-CoV-2 Coronavirus Available from bioMérieux
finance.yahoo.com - March 11 at 5:00 AM
Race in full-stride for tests to identify coronavirus illnessRace in full-stride for tests to identify coronavirus illness
seekingalpha.com - March 3 at 3:20 PM
bioMérieux S.A. Full-Year Results: Here's What Analysts Are Forecasting For Next YearbioMérieux S.A. Full-Year Results: Here's What Analysts Are Forecasting For Next Year
finance.yahoo.com - February 28 at 12:37 AM
Announcing: bioMérieux (EPA:BIM) Stock Increased An Energizing 175% In The Last Five YearsAnnouncing: bioMérieux (EPA:BIM) Stock Increased An Energizing 175% In The Last Five Years
finance.yahoo.com - January 31 at 8:27 AM
bioMérieux submits enhanced BIOFIRE® BCID2 Panel for FDA clearancebioMérieux submits enhanced BIOFIRE® BCID2 Panel for FDA clearance
finance.yahoo.com - January 14 at 2:56 AM
bioMérieux and the Fleming Fund: working together to strengthen diagnostic capacity and tackle antimicrobial resistance in low- and middle-income countriesbioMérieux and the Fleming Fund: working together to strengthen diagnostic capacity and tackle antimicrobial resistance in low- and middle-income countries
finance.yahoo.com - December 18 at 1:18 AM
Where bioMérieux S.A.'s (EPA:BIM) Earnings Growth Stands Against Its IndustryWhere bioMérieux S.A.'s (EPA:BIM) Earnings Growth Stands Against Its Industry
finance.yahoo.com - December 17 at 9:21 AM
Here's What bioMérieux S.A.'s (EPA:BIM) P/E Ratio Is Telling UsHere's What bioMérieux S.A.'s (EPA:BIM) P/E Ratio Is Telling Us
finance.yahoo.com - November 11 at 8:06 AM
Biomerieux SA (BMXMF) Revenue EPSBiomerieux SA (BMXMF) Revenue EPS
www.nasdaq.com - November 7 at 5:25 PM
These 4 Measures Indicate That bioMérieux (EPA:BIM) Is Using Debt Reasonably WellThese 4 Measures Indicate That bioMérieux (EPA:BIM) Is Using Debt Reasonably Well
finance.yahoo.com - October 15 at 7:58 AM
Is bioMérieux S.A.'s (EPA:BIM) 12% ROE Strong Compared To Its Industry?Is bioMérieux S.A.'s (EPA:BIM) 12% ROE Strong Compared To Its Industry?
finance.yahoo.com - September 23 at 7:41 AM
What Kind Of Shareholders Own bioMérieux S.A. (EPA:BIM)?What Kind Of Shareholders Own bioMérieux S.A. (EPA:BIM)?
finance.yahoo.com - August 28 at 10:15 AM
T2 Biosystems: Failed Product Launch And Covenant Violations Suggest 100% DownsideT2 Biosystems: Failed Product Launch And Covenant Violations Suggest 100% Downside
seekingalpha.com - May 23 at 11:28 AM
Edited Transcript of BIM.PA earnings conference call or presentation 27-Feb-19 1:30pm GMTEdited Transcript of BIM.PA earnings conference call or presentation 27-Feb-19 1:30pm GMT
finance.yahoo.com - April 4 at 4:25 PM
BIOMERIEUX (BMXMF) Upgraded to Buy: What Does It Mean for the Stock?BIOMERIEUX (BMXMF) Upgraded to Buy: What Does It Mean for the Stock?
finance.yahoo.com - March 13 at 11:39 AM
This page was last updated on 4/16/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.